Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled Trial

BACKGROUND: End-stage kidney disease patients on dialysis have a substantial risk of polypharmacy due their propensity for comorbidity and contact with the health care system. MedSafer is an electronic decision support tool that integrates patient comorbidity and medication lists to generate persona...

Descripción completa

Detalles Bibliográficos
Autores principales: Moryousef, Joseph, Bortolussi-Courval, Émilie, Podymow, Tiina, Lee, Todd C., Trinh, Emilie, McDonald, Emily G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Clinical Research Quantitative
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109480/
https://www.ncbi.nlm.nih.gov/pubmed/35586025
http://dx.doi.org/10.1177/20543581221098778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109480/
https://www.ncbi.nlm.nih.gov/pubmed/35586025
http://dx.doi.org/10.1177/20543581221098778

Ejemplares similares